FDA clears Fiber Imaging Technologies' flexible endoscope:
This article was originally published in Clinica
Executive Summary
Fiber Imaging Technologies (FIT) and its German partner Schoelly Fiberoptic have received US FDA 510(k) clearance for their flexible, steerable endoscope for use during larynx and pharynx diagnostic examinations. The naso-laryngo-pharyngoscope has a working length of 300mm, a deflection range of 150 degrees up or down, a 25mm flexible tip section and a wide-angled field of view. It provides a sharp image, panoramic or detailed examination and one-handed operation during diagnostic procedures, said Worcester, Massachusetts-based FIT, a subsidiary of Luxtec, also based in Worcester.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.